Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

FMS

Fresenius Medical Care (FMS)

Fresenius Medical Care AG
일자:
정렬 기준:
 검색 관련기사 보기:NYSE:FMS
일자시간출처헤드라인심볼기업
2025/02/2521:00PR Newswire (US)Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025NYSE:FMSFresenius Medical Care AG
2025/02/2422:00PR Newswire (US)Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest DiagnosticsNYSE:FMSFresenius Medical Care AG
2024/12/2323:00PR Newswire (US)Fresenius Medical Care Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe IndexNYSE:FMSFresenius Medical Care AG
2024/12/2101:23PR Newswire (US)Fresenius Medical Care returns to Dax 40 IndexNYSE:FMSFresenius Medical Care AG
2024/11/1923:00PR Newswire (US)Fresenius Medical Care Awarded Mechanical Circulatory Support Agreement with Premier, Inc. for the Novalung® ECMO SystemNYSE:FMSFresenius Medical Care AG
2024/11/0600:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:FMSFresenius Medical Care AG
2024/11/0521:00PR Newswire (US)Fresenius Medical Care reports strong operating income margin growth in the third quarter of 2024NYSE:FMSFresenius Medical Care AG
2024/11/0520:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:FMSFresenius Medical Care AG
2024/10/2200:04PR Newswire (US)Fresenius Medical Care Showcases Research and Innovations in Kidney Care at American Society of Nephrology (ASN) Kidney Week 2024NYSE:FMSFresenius Medical Care AG
2024/09/0421:00PR Newswire (US)Fresenius Medical Care Grows Number of U.S. Patients Using Company's Home Hemodialysis Machines, Launches NxStage® Versi®HD with GuideMe SoftwareNYSE:FMSFresenius Medical Care AG
2024/07/3022:43Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:FMSFresenius Medical Care AG
2024/07/3020:00PR Newswire (US)Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024NYSE:FMSFresenius Medical Care AG
2024/07/3019:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:FMSFresenius Medical Care AG
2024/06/1221:00PR Newswire (US)Fresenius Medical Care takes next important step towards goal to reduce CO2 emissions in its operationsNYSE:FMSFresenius Medical Care AG
2024/05/2403:11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:FMSFresenius Medical Care AG
2024/05/2401:33PR Newswire (US)Moody's and S&P change Fresenius Medical Care's rating outlook to stableNYSE:FMSFresenius Medical Care AG
2024/05/2123:00PR Newswire (US)Fresenius Medical Care showcases leadership and innovation in kidney care disease at 61st European Renal Association (ERA) Congress 2024NYSE:FMSFresenius Medical Care AG
2024/05/1623:35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:FMSFresenius Medical Care AG
2024/05/1622:55PR Newswire (US)Fresenius Medical Care Annual General Meeting: Company makes significant progress in its Transformation Efforts and confirms its ambitious 2024 Growth TargetsNYSE:FMSFresenius Medical Care AG
2024/05/0720:00PR Newswire (US)Fresenius Medical Care starts the year with strong earnings growthNYSE:FMSFresenius Medical Care AG
2024/03/2221:00PR Newswire (US)Fresenius Medical Care publishes 2023 joint Annual Report and Sustainability Report: Shaping the Future of Kidney CareNYSE:FMSFresenius Medical Care AG
2024/03/1921:00PR Newswire (US)Fresenius Medical Care launches "Augmented Reality" for training on Kidney Replacement Therapy deviceNYSE:FMSFresenius Medical Care AG
2024/03/1323:00PR Newswire (US)Fresenius Medical Care appoints Jörg Häring as new Management Board member responsible for Legal, Compliance and Human ResourcesNYSE:FMSFresenius Medical Care AG
2024/03/0600:48Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:FMSFresenius Medical Care AG
2024/03/0600:10PR Newswire (US)Fresenius Medical Care Achieves Next Milestone in Portfolio Optimization Program, Announcing Sale of Dialysis Clinics in Brazil, Colombia, Chile, EcuadorNYSE:FMSFresenius Medical Care AG
2024/02/2101:17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:FMSFresenius Medical Care AG
2024/02/2100:22Edgar (US Regulatory)Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).NYSE:FMSFresenius Medical Care AG
2024/02/2100:02Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NYSE:FMSFresenius Medical Care AG
2024/02/2021:30PR Newswire (US)Fresenius Medical Care delivers on commitments in a year of fundamental transformationNYSE:FMSFresenius Medical Care AG
2024/02/2020:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:FMSFresenius Medical Care AG
 검색 관련기사 보기:NYSE:FMS